Investigation on the Molecular Interactions Stabilizing the Structure of α-synuclein Fibril : An In silico Study
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.org..
BACKGROUND: Amyloid fibrils represent stable form of many misfolded proteins associated with numerous diseases like Parkinson's Disease (PD), Type II diabetes and Alzheimer's disease (AD). α-synuclein protein is the principal constituent of Lewy bodies that are considered to be pathological hallmark of PD. Recently, a high resolution structure of α-synuclein protein that stacks together forming fibrils in brains of PD patients were identified. What structural features drive pathology of PD can now be possibly answered from the fibril structure of protein.
OBJECTIVES: To understand the molecular interactions those are responsible for the stability of the α- synuclein fibril structure.
METHODS: To study the molecular interactions stabilizing the α-synuclein fibril, we have used a high resolution amyloid fibril structure (PDB ID 2N0A). The molecular interactions in fibril structure were studied using PDBSum server. We then looked into the destabilization of α-synuclein fibril by disrupting the salt-bridge holding the strands and probable methods to decompose fibril into structurally distinct units using Top-domain web-server. The effect of salt-bridges on the stability of the fibril structure was studied by mutating one of the residues involved in the formation of salt-bridge using molecular dynamics simulation.
RESULTS: Our results indicate a finite salt-bridge (E46-K80) is crucial for stability of protofibril. Besides, we observed hydrogen bonds and non-bonded contacts involved in fibril stabilization. We noticed α-synuclein dimer predominantly exists in conformations distinct from fibril.
CONCLUSION: We characterized the salient molecular interactions in α-synuclein fibril and these findings may be useful to design potential inhibitors for the treatment of PD.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Central nervous system agents in medicinal chemistry - 17(2017), 3 vom: 10., Seite 209-218 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sanjeev, Airy [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
α-synuclein fibril |
|---|
| Anmerkungen: |
Date Completed 21.06.2018 Date Revised 21.06.2018 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/1871524917666170427152849 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM271464372 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM271464372 | ||
| 003 | DE-627 | ||
| 005 | 20231224232747.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1871524917666170427152849 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0904.xml |
| 035 | |a (DE-627)NLM271464372 | ||
| 035 | |a (NLM)28460628 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sanjeev, Airy |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Investigation on the Molecular Interactions Stabilizing the Structure of α-synuclein Fibril |b An In silico Study |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.06.2018 | ||
| 500 | |a Date Revised 21.06.2018 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.org. | ||
| 520 | |a BACKGROUND: Amyloid fibrils represent stable form of many misfolded proteins associated with numerous diseases like Parkinson's Disease (PD), Type II diabetes and Alzheimer's disease (AD). α-synuclein protein is the principal constituent of Lewy bodies that are considered to be pathological hallmark of PD. Recently, a high resolution structure of α-synuclein protein that stacks together forming fibrils in brains of PD patients were identified. What structural features drive pathology of PD can now be possibly answered from the fibril structure of protein | ||
| 520 | |a OBJECTIVES: To understand the molecular interactions those are responsible for the stability of the α- synuclein fibril structure | ||
| 520 | |a METHODS: To study the molecular interactions stabilizing the α-synuclein fibril, we have used a high resolution amyloid fibril structure (PDB ID 2N0A). The molecular interactions in fibril structure were studied using PDBSum server. We then looked into the destabilization of α-synuclein fibril by disrupting the salt-bridge holding the strands and probable methods to decompose fibril into structurally distinct units using Top-domain web-server. The effect of salt-bridges on the stability of the fibril structure was studied by mutating one of the residues involved in the formation of salt-bridge using molecular dynamics simulation | ||
| 520 | |a RESULTS: Our results indicate a finite salt-bridge (E46-K80) is crucial for stability of protofibril. Besides, we observed hydrogen bonds and non-bonded contacts involved in fibril stabilization. We noticed α-synuclein dimer predominantly exists in conformations distinct from fibril | ||
| 520 | |a CONCLUSION: We characterized the salient molecular interactions in α-synuclein fibril and these findings may be useful to design potential inhibitors for the treatment of PD | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Amyloid | |
| 650 | 4 | |a fibrillation | |
| 650 | 4 | |a molecular dynamics | |
| 650 | 4 | |a oligomerization | |
| 650 | 4 | |a parkinson's disease | |
| 650 | 4 | |a α-synuclein fibril | |
| 650 | 7 | |a Amyloid |2 NLM | |
| 650 | 7 | |a Protein Aggregates |2 NLM | |
| 650 | 7 | |a alpha-Synuclein |2 NLM | |
| 700 | 1 | |a Mattaparthi, Venkata S K |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Central nervous system agents in medicinal chemistry |d 2008 |g 17(2017), 3 vom: 10., Seite 209-218 |w (DE-627)NLM185149960 |x 1875-6166 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2017 |g number:3 |g day:10 |g pages:209-218 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1871524917666170427152849 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2017 |e 3 |b 10 |h 209-218 | ||